广东东峰新材料集团股份有限公司 章 程 （经 2023 年 8 月 29 日公司第五届董事会第二次会议审议通过） - 1 - 目录 第一章 总则 第二章 经营宗旨和范围 第三章 股份 第四章 股东和股东大会 第五章 董事会 第六章 总经理和其他高级管理人员 第七章 监事会 - 2 - 第一节 股份发行 第二节 股份增减和回购 第三节 股份转让 第一节 股东 第二节 股东大会的一般规定 第三节 股东大会的召集 第四节 股东大会的提案与通知 第五节 股东大会的召开 第六节 股东大会的表决和决议 第一节 董事 第二节 独立董事 第三节 董事会 第一节 监事 第二节 监事会 第八章 财务会计制度、利润分配和审计 第一节 财务会计制度 第二节 内部审计 第三节 会计师事务所的聘任 第九章 通知 第一节 通知 第二节 公告 第十章 合并、分立、增资、减资、解散和清算 第一节 合并、分立、增资和减资 第二节 解散和清算 第十一章 修改章程 第十二章 附则 - 3 - 广东东峰新材料集团股份有限公司 章程 第一章 总则 第一条 为维护公司、股东和债权人的合法权益，规范公司的组织和行为，根据《中 华人民共和国公司法》（以下简称 ...

证券代码：601515 证券简称：东风股份 公告编号：临 2023-061 汕头东风印刷股份有限公司 第五届监事会第二次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 汕头东风印刷股份有限公司（以下简称"公司"）第五届监事会第二次会议 于 2023 年 8 月 29 日在公司会议室召开，应到监事三名，实到监事三名，符合《公 司法》和《公司章程》的相关规定。会议由监事会主席马惠平主持。 经全体与会监事讨论和表决，审议通过以下议案： 一、审议通过《公司 2023 年半年度报告及其摘要》； 1、监事会对《公司 2023 年半年度报告及其摘要》进行了审核，认为报告编 制和审议程序符合法律、法规、《公司章程》和公司内部管理制度的各项规定。 3、监事会认为《公司 2023 年半年度报告及其摘要》内容真实、准确和完整， 不存在虚假记载、误导性陈述和重大遗漏。 4、监事会在提出本意见前，没有发现参与《公司 2023 年半年度报告及其摘 要》编制和审议的人员有违反保密规定的行为。 《公司 2023 年半年度报告及其摘要》内容详见上 ...

证券代码：601515 证券简称：东风股份 公告编号：临 2023-062 汕头东风印刷股份有限公司 关于 2023 年半年度募集资金存放与实际使用情况 的专项报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 根据中国证券监督管理委员会（以下简称"中国证监会"）《上市公司监管指 引第 2 号——上市公司募集资金管理和使用的监管要求（2022 年修订）》（证监会 公告[2022]15 号）、《上海证券交易所上市公司自律监管指引第 1 号——规范运作》 （上证发[2022]2 号）等相关规则规定，现将汕头东风印刷股份有限公司（以下简 称"东风股份"或"公司"）2020 年度非公开发行 A 股股票的募集资金在 2023 年 半年度的存放与使用情况进行说明。 一、募集资金基本情况 （一）实际募集资金金额和资金到账情况 经中国证券监督管理委员会《关于核准汕头东风印刷股份有限公司非公开发 行股票的批复》（证监许可[2021]611 号）文件核准，公司以非公开发行股票方式向 特定对象发行人民币普通股（A 股）股票 201,320,132 ...

证券代码：601515 证券简称：东风股份 公告编号：临 2023-060 汕头东风印刷股份有限公司 第五届董事会第二次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 汕头东风印刷股份有限公司（以下简称"公司"）第五届董事会第二次会议 于 2023 年 8 月 29 日在公司会议室以现场结合通讯方式召开，会议通知于 2023 年 8 月 19 日以电话、短信和电子邮件等方式送达全体董事，并于 2023 年 8 月 27 日发出补充通知，对本次会议审议事项进行调整。本次会议应出席董事 7 名， 实际出席 7 名，会议召开符合法律、法规、规章及《公司章程》的规定。 一、审议通过《公司 2023 年半年度报告及其摘要》； 《公司 2023 年半年度报告及其摘要》内容详见上海证券交易所网站 www.sse.com.cn。 议案表决情况：本议案有效表决票 7 票，同意 7 票，反对 0 票，弃权 0 票。 二、审议通过《公司 2023 年半年度募集资金存放与实际使用情况的专项报 告》； 《公司 2023 年半年度募集资金存 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 汕头东风印刷股份有限公司（以下简称"公司"）于 2023 年 8 月 29 日召开 第五届董事会第二次会议、第五届监事会第二次会议，审议通过了《关于终止发 行股份及支付现金购买资产事项并撤回申请文件的议案》、《关于公司与交易对 方签署相关终止协议的议案》，综合考虑当前外部市场环境和标的公司经营情况 等因素，为切实维护上市公司和广大投资者利益，经公司审慎研究并与交易对方 友好协商，同意终止本次重组事项并向上海证券交易所申请撤回本次重组相关申 请文件。现将有关事项公告如下： 一、本次交易的基本情况 公司拟以发行股份及支付现金方式购买顾军、陈燕、深圳市博睿创新投资企 业（有限合伙）、深圳市博昱创新投资企业（有限合伙）、宁波梅山保税港区双 德创业投资合伙企业（有限合伙）、熊杰、曾斌、樊华（以下合称"交易对方"） 合计持有的深圳市博盛新材料有限公司（以下简称"博盛新材"或"标的公司"） 51.05653%股权（以下统称"本次交易"、"本次重组"）。 证券代码：601515 证券简称：东风股 ...

关于 汕头东风印刷股份有限公司 终止发行股份及支付现金购买资产事项之 核查意见 独立财务顾问 华泰联合证券有限责任公司 二〇二三年八月 华泰联合证券有限责任公司（以下简称"独立财务顾问"）作为汕头东风印 刷股份有限公司（以下简称"公司"）拟发行股份及支付现金购买资产（以下简称 "本次重组"）的独立财务顾问，根据《上海证券交易所上市公司自律监管指引第 6 号——重大资产重组》等相关法律法规的规定，审慎核查了本次重组的历程及 终止原因，并根据核查确认的相关情况出具独立财务顾问核查意见（以下简称"本 核查意见"）如下： 一、本次重组的基本情况 公司拟以发行股份及支付现金方式购买深圳市博盛新材料有限公司（以下简 称"博盛新材"）股东顾军、陈燕、深圳市博睿创新投资企业（有限合伙）、深 圳市博昱创新投资企业（有限合伙）、宁波梅山保税港区双德创业投资合伙企业 （有限合伙）、熊杰、曾斌、樊华合计持有的博盛新材 51.06%股权（以下简称 "本次交易"、"本次重组"）。 二、上市公司在推进本次重组期间所做的主要工作 在本次交易相关工作的推进过程中，公司严格按照规定及时履行信息披露义 务，并在重组预案及其他相关公告中对相关风险进 ...

关于对外投资设立控股子公司暨关联交易的公告 证券代码：601515 证券简称：东风股份 公告编号：临 2023-065 汕头东风印刷股份有限公司 汕头东风印刷股份有限公司（以下简称"公司"）全资子公司汕头东峰医药 包装有限公司（以下简称"汕头东峰"）、控股子公司重庆首键药用包装材 料有限公司（以下简称"首键药包"）拟与自然人张凯先生、唐光文先生、 徐国鑫先生共同出资设立控股子公司重庆东峰首键药用玻璃包装有限公司 （以下简称"东峰首键"），其中汕头东峰认缴出资人民币 3,100 万元，持 有东峰首键 62%的股权；首键药包认缴出资人民币 750 万元，持有东峰首键 15%的股权。 根据《上海证券交易所股票上市规则》和《上海证券交易所上市公司自律监 管指引第 5 号——交易与关联交易》的相关规定，因本次拟共同出资设立东 峰首键的主体包括公司集团副总裁张凯先生，故本次共同对外投资构成关联 交易。 除本次共同对外投资涉及关联交易外，过去 12 个月内公司未与同一关联人发 生其他关联交易及与不同关联人发生共同对外投资类别相关的关联交易。 本次共同对外投资不构成重大资产重组。 风险提示： 药用玻璃瓶制瓶机等相关生产设施、 ...

证券代码：601515 证券简称：东风股份 公告编号：2023-059 汕头东风印刷股份有限公司 股东及董事兼高级管理人员集中竞价减持股份 计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 大股东持股的基本情况：汕头东风印刷股份有限公司（以下简称"公 司"）大股东东捷控股有限公司（以下简称"东捷控股"）直接持有公 司无限售条件流通股股份 102,255,700 股，直接持股比例为 5.55%；东 捷控股之一致行动人合计直接持有公司无限售条件流通股股份 927,612,582 股，合计直接持股比例为 50.33%； 董事兼高级管理人员持股的基本情况：公司董事兼集团总裁王培玉先 生直接持有公司无限售条件流通股股份 2,879,993 股，直接持股比例 为 0.16%；公司董事兼集团财务总监李治军先生直接持有公司无限售条 件流通股股份 2,303,994 股，直接持股比例为 0.13%；公司董事兼集团 副总裁谢名优先生直接持有公司无限售条件流通股股份 1,440,323 股， 直接持股比例为 0.0 ...

Financial Performance - The company's operating revenue for 2022 was CNY 3,744,006,025.02, a decrease of 1.60% compared to CNY 3,805,071,241.70 in 2021[22]. - The net profit attributable to shareholders for 2022 was CNY 289,255,701.31, down 63.15% from CNY 785,051,321.30 in 2021[22]. - The basic earnings per share for 2022 was CNY 0.17, a decline of 70.18% compared to CNY 0.57 in 2021[23]. - The weighted average return on equity for 2022 was 5.04%, a decrease of 11.5 percentage points from 16.54% in 2021[23]. - The net cash flow from operating activities for 2022 was CNY 687,776,816.70, a slight decrease of 0.47% from CNY 691,049,427.97 in 2021[22]. - The total assets at the end of 2022 were CNY 8,162,938,834.70, an increase of 1.55% from CNY 8,038,377,757.79 at the end of 2021[22]. - The net assets attributable to shareholders at the end of 2022 were CNY 5,571,244,198.88, down 6.78% from CNY 5,976,718,862.98 at the end of 2021[22]. - The company reported a total revenue of 91,174.21 million for the year, with a net profit of 10,226.66 million, reflecting a significant growth compared to the previous year[124]. - The company’s net profit attributable to shareholders decreased by 63.15% to ¥289,255,701.31 compared to the previous year[89]. - The company reported a significant decrease in investment income by 98.66% to ¥6,032,769.27, primarily due to the decline in the market value of investments[89]. Strategic Focus and Investments - The company is committed to future development strategies but warns investors about potential investment risks[7]. - The company is focusing on the new energy and new materials business as a core growth area, with significant investments planned[34]. - The company has invested RMB 4 billion in subsidiaries for the development of new energy materials and related projects[35]. - The company plans to establish a research and development center to enhance its capabilities in new energy materials[35]. - The company aims to build a strong resource base for the next five years in the new materials sector through strategic partnerships and talent acquisition[35]. - The company plans to invest CNY 5 billion in a smart manufacturing base for high-barrier pharmaceutical packaging materials and CNY 4 billion for a smart manufacturing base for drug bottle caps, expected to enhance production scale and operational efficiency[49]. - The company plans to increase investment in core sectors such as new energy materials and Class I pharmaceutical packaging, focusing resources to accelerate development[138]. - The company is actively seeking new acquisition targets to expand its portfolio in pharmaceutical auxiliary materials and medical devices[142]. - The company plans to invest in key business segments such as new energy materials and pharmaceutical packaging, with ongoing projects including a production base for medical packaging with an annual capacity of 12 billion units[158]. Market Position and Growth - The company has a diverse portfolio of subsidiaries involved in various sectors, including packaging and printing[11]. - The company achieved a 59% year-on-year increase in lithium battery separator shipments, totaling 12.4 billion square meters, driven by the rapid growth of the energy storage market and the expansion of the lithium battery industry[45]. - The company is focusing on R&D for high-end materials to enhance oxygen and moisture barrier properties, laying a solid technical foundation for supplying high-end pharmaceutical products and mRNA vaccine products[39]. - The company is strategically transforming towards the new energy materials sector, planning to acquire a 51.06% stake in Shenzhen Boson New Materials Co., indicating a commitment to expanding its presence in the new energy materials market[42]. - The company is leveraging its competitive advantages in production base layout, cost control, and quality management to strengthen its printing and packaging business, while also diversifying into social packaging and consumer-facing printing services[41]. - The company is actively expanding its foreign pharmaceutical client base, which includes high-quality customers like Bayer, indicating a robust growth strategy in international markets[38]. - The company is focusing on enhancing its R&D capabilities in new energy materials, particularly in battery separators and other composite materials, to establish a strong market position[140]. Compliance and Governance - The company received a standard unqualified audit report from Suya Jin Cheng Accounting Firm for the fiscal year[5]. - The board of directors and management confirmed the authenticity, accuracy, and completeness of the annual report[4]. - The company emphasizes the importance of compliance with relevant laws and regulations in its operations[4]. - The company has not reported any significant asset restructuring or major asset and equity sales during the reporting period[121]. - The company has not engaged in significant non-equity investments during the reporting period[120]. - The company has not faced any penalties from securities regulatory agencies in the past three years[175]. - The company has continued to enhance transparency and ensure equal access to information for all investors regarding significant matters and management operations[163]. Human Resources and Management - The company has implemented various talent development programs, including the "Sailing Plan" and "Leading Plan," to enhance the skills of mid-to-senior management[187]. - The company has a total of 602 employees with a bachelor's degree or higher, representing approximately 14.2% of the total workforce[185]. - The company has a total of 1,675 employees with a college diploma or vocational training, accounting for approximately 39.5% of the total workforce[185]. - The company has a total of 1,963 employees with a high school education or below, making up about 46.3% of the total workforce[185]. - The company has 121 retired employees for whom it bears costs[185]. - The company is focusing on enhancing human resource management to align with its strategic transformation, particularly in high-level management, business, and technical talent[152]. Environmental and Social Responsibility - The company invested approximately 17.5 million yuan in environmental protection during the reporting period[199]. - The company and its subsidiary, Guangdong Xinrui New Materials Technology Co., Ltd., were listed as key pollutant discharge units in Shantou City for 2022[200]. - The company complied with all emission standards for waste gas, wastewater, and noise during the reporting period, with no violations or penalties reported[200]. - The company is committed to sustainability initiatives, with plans to reduce carbon emissions by 20% over the next five years[168]. Risks and Challenges - The company is facing risks from industry upgrades and intensified competition, necessitating continuous R&D investment and technological improvements to maintain competitiveness[154]. - Environmental regulations are increasing production management requirements, leading to potential rises in related expenditures, prompting the company to invest in eco-friendly technologies[156]. - The company is actively monitoring and adjusting its investment projects in response to changes in industry trends and market conditions to ensure smooth project execution[158].

Financial Performance - The company's operating revenue for Q1 2023 was ¥916,139,419.86, a decrease of 12.49% compared to the same period last year[5] - Net profit attributable to shareholders was ¥224,862,307.83, an increase of 85.48% year-on-year[5] - Basic and diluted earnings per share were both ¥0.120, reflecting a 50.00% increase compared to the previous year[5] - Total operating revenue for Q1 2023 was ¥916,139,419.86, a decrease of 12.5% compared to ¥1,046,944,762.51 in Q1 2022[15] - Net profit for Q1 2023 reached ¥229,962,471.70, an increase of 85.5% from ¥123,932,410.77 in Q1 2022[15] - Operating profit for Q1 2023 was ¥252,001,680.51, compared to ¥126,890,198.88 in Q1 2022, reflecting a significant improvement[15] - Earnings per share for Q1 2023 were ¥0.12, up from ¥0.08 in Q1 2022[16] - The company’s total comprehensive income for Q1 2023 was ¥107.86 million, compared to ¥21.10 million in Q1 2022, reflecting a strong performance[28] Assets and Liabilities - Total assets at the end of the reporting period were ¥8,074,932,854.92, a decrease of 1.08% from the end of the previous year[6] - Total assets as of March 31, 2023, were RMB 8,074,932,854.92, compared to RMB 8,162,938,834.70 at the end of 2022, reflecting a decline of approximately 1.1%[12] - The company's total assets as of March 31, 2023, were CNY 6,186,453,685.38, slightly up from CNY 6,173,936,962.15 at the end of 2022[24] - The total liabilities decreased to ¥1,856,009,680.29 in Q1 2023 from ¥2,159,942,649.60 in Q1 2022, indicating a reduction of approximately 14.1%[15] - The company's total liabilities decreased to CNY 714,719,949.95 from CNY 810,084,741.81 at the end of 2022[24] - The company’s total liabilities decreased to RMB 3,840,663,087.48 from RMB 4,321,425,724.09, reflecting a reduction of approximately 11.1%[12] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 44,092[9] - The largest shareholder, Hong Kong Dongfeng Investment Group Co., Ltd., held 47.26% of the shares[9] - Shareholders' equity attributable to the parent company increased by 4.01% to ¥5,794,608,767.66[6] Cash Flow and Investments - In Q1 2023, the company's cash inflow from operating activities was CNY 738,518,110.76, a decrease of 9.5% compared to CNY 816,174,564.43 in Q1 2022[19] - The net cash flow from operating activities was -CNY 229,337,793.22, worsening from -CNY 45,579,918.95 in the same period last year[20] - The company reported a net cash inflow from investing activities of CNY 17,529,726.25, a significant improvement from -CNY 73,971,219.64 in Q1 2022[20] - The total cash and cash equivalents at the end of Q1 2023 were CNY 1,682,674,492.51, down from CNY 2,259,853,503.11 at the end of Q1 2022[20] - The cash outflow from financing activities was -CNY 25,671,371.95, compared to -CNY 2,437,219.19 in Q1 2022, indicating increased cash usage for financing[20] Inventory and Receivables - Accounts receivable increased to RMB 734,870,652.56, up from RMB 589,218,449.90, representing a growth of about 24.7%[11] - Inventory decreased to RMB 562,335,253.52 from RMB 757,130,482.35, indicating a reduction of approximately 25.7%[12] - The company reported a notable increase in other receivables, rising to RMB 185,222,153.80 from RMB 108,399,729.68, a growth of about 71.0%[11] - The company’s inventory decreased significantly to CNY 26,576,026.94 from CNY 211,981,493.49, reflecting improved inventory management[23] - The accounts receivable increased to CNY 190,406,390.93 from CNY 193,071,984.00, indicating a stable collection period[23] Research and Development - The company reported a significant reduction in research and development expenses, which fell to ¥4.70 million from ¥12.13 million, a decrease of 61.2%[27] Tax and Financial Expenses - The company reported a tax expense of ¥21,603,194.36 for Q1 2023, compared to ¥2,415,484.18 in Q1 2022, indicating a higher tax burden due to increased profitability[15] - The company's financial expenses showed a notable improvement, with a net financial cost of -¥386,051.11 in Q1 2023 compared to -¥1.99 million in Q1 2022[27]